Hers vs Sprout Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Sprout Health beats Hers overall, scoring 8.8/10 vs 7.3/10. Hers is more affordable at $199/mo vs $249/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Sprout Health for users looking for a reliable mid-range option with proven co.

A side-by-side comparison of Hers and Sprout Health covering pricing, scores, medication types, insurance, and more to help you decide.

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Higher Rated

Sprout Health

#2 of 48

8.8/10

Well-established telehealth provider offering both compounded and brand-name GLP-1 medications with solid clinical support.

Visit Sprout Health

Feature	Hers	Sprout Health
Our Score	7.3/10	8.8/10
Starting Price	$199/mo	$249/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Users looking for a reliable mid-range option with proven conversion
Ranking	#35	#2

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Sprout Health

Pros

+Operating since 2022 with a consistent track record — no sudden pricing changes or service disruptions
+Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
+Dedicated care coordinator assigned to each patient — not a rotating pool of providers
+Transparent pricing: $250/mo covers medication, shipping, and all consultations

Cons

−$250/mo puts it in the upper-mid range — $90 more than Willow for a similar all-inclusive model
−No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Our Verdict

Sprout Health edges out Hers with a score of 8.8/10 vs 7.3/10. If budget is your priority, Hers starts at $199/mo compared to Sprout Health's $249/mo. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Sprout Health if you want: users looking for a reliable mid-range option with proven conversion.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor Sprout Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review